PanopticAI Vital Signs
Dec 2024
266d
PanopticAI technologies Limited has submitted 1 FDA 510(k) premarket notifications since 2024, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Software For Optical Camera-based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/or Respiratory Rate . Use the specialty filter in the sidebar to narrow results.